About Vats Biotech
Vats Biotech is a Healthcare company founded in 2015. Developing and marketing affordable healthcare products, focusing on pharmaceuticals and vaccines in India. The company has 30 employees. Its Indian entity Vats Biotech Private Limited reported revenue of ₹13.73 Cr. Vats Biotech offers products and services including Generic Drugs and Vaccines. Its focus areas include Pharmaceuticals, Generic Drugs, Vaccines and Manufacturing.
Company details
Vats Biotech Private Limited is engaged in the development and marketing of affordable healthcare products, particularly generic drugs and vaccines. India is noted for supplying over 50 of global vaccine demand and ranking third in pharmaceutical production by volume. The company is positioned to grow through strategic market penetration, supported by a dedicated team that prioritizes quality and affordability. The domestic pharmaceutical market is expected to expand from US 42 billion in 2021 to US 120-130 billion by 2030, with exports contributing significantly. Efforts are directed towards meeting rising global needs while maintaining high standards.
- Employees 30
- SectorsHealthcare
- Email••••••••
- Website vatsbiotech.com
- Social LinkedIn X Facebook Instagram
- Legal Name Vats Biotech Private Limited
- Date of Incorporation 07 Jul, 2015
- Jurisdiction Jamshedpur, Jharkhand, India
- Indian entity revenue₹13.73 Cr
FY 2026 · -44% YoY
- Indian entity net profit₹17.1 Lakh
FY 2026 · 1% margin
- Indian entity EBITDA₹24.8 Lakh
FY 2026 · 2% margin
- Employee Count30
Associated legal entities of Vats Biotech
Vats Biotech operates through Vats Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vats Biotech Private Limited CIN U52310JH2015PTC003021 | Active | 07 Jul 2015 | Jamshedpur, Jharkhand | ₹13.7 Cr | 30 | 4 | View details |
Products & Services of Vats Biotech
Vats Biotech offers a comprehensive portfolio of products and services, including Generic Drugs and Vaccines.
Generic drugs and vaccines are developed and marketed to provide affordable healthcare solutions
Vaccines are supplied to meet global demands, with emphasis on quality and affordability in production
Board of directors of Vats Biotech Private Limited (Vats Biotech)
Vats Biotech Private Limited is the primary company behind Vats Biotech. The board of Vats Biotech Private Limited currently have 4 directors; the longest-serving is Ashish Kumar Jha, appointed in 2015. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashish Kumar Jha DIN 07173396 | Director | 07 Jul 2015 | 11 yrs 4 mo | Vats Biotech Private Limited |
| Rani Kumari DIN 07701739 | Additional Director | 17 Feb 2017 | 9 yrs 8 mo | Vats Biotech Private Limited |
| Preeti Jha DIN 07702151 | Additional Director | 17 Feb 2017 | 9 yrs 8 mo | Vats Biotech Private Limited |
| Brajesh Kumar Singh DIN 09422352 | Additional Director | 12 Nov 2021 | 4 yrs 11 mo | Vats Biotech Private Limited |
Financials of Vats Biotech
Figures of Vats Biotech Private Limited, the primary company behind Vats Biotech, for FY 2026. Revenue was ₹13.73 Cr (-44% year on year). Net profit was ₹17.1 Lakh (1% margin). EBITDA was ₹24.8 Lakh (2% margin). Revenue has grown at a compounded annual rate of -1% over three years and +48% over five years.
- ₹13.73 CrRevenue · FY 2026 · -44% YoY
- ₹17.1 LakhNet profit · 1% margin
- ₹24.8 LakhEBITDA · 2% margin
- ₹40 LakhPaid-up capital
- 30Employees (provident fund records)
- -1%Revenue CAGR, 3 years
- +48%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vats Biotech Private Limited are on its company page.
Detailed financial statements for Vats Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vats Biotech
Vats Biotech was founded in 2015.
Vats Biotech has 30 employees.
The primary company behind Vats Biotech, Vats Biotech Private Limited, reported revenue of ₹13.73 Cr for FY 2026, down 44% year on year.
Vats Biotech Private Limited is engaged in the development and marketing of affordable healthcare products, particularly generic drugs and vaccines. India is noted for supplying over 50 of global vaccine demand and ranking third in pharmaceutical production by volume. The company is positioned to grow through strategic market penetration, supported by a dedicated team that prioritizes quality and affordability. The domestic pharmaceutical market is expected to expand from US 42 billion in 2021 to US 120-130 billion by 2030, with exports contributing significantly. Efforts are directed towards meeting rising global needs while maintaining high standards.
Vats Biotech offers Generic Drugs and Vaccines.
Vats Biotech operates through Vats Biotech Private Limited.
The legal entities of Vats Biotech currently have 4 directors, including Rani Kumari, Brajesh Kumar Singh, Preeti Jha and others.